Abstract
Monsanto and San Diego-based Mycogen are at it again. A California jury has awarded Mycogen $175 million in damages as a result of Monsanto's foot-dragging on granting a license for its technology for genetically engineering insect-and herbicide- resistant plants. We are gratified that the jury has held Monsanto accountable for the negative impact the delay in receiving this technology has had on our seed business, says Carl Eibl, president of a biotechnology and agribusiness company 69% owned by Dow Chemical. Monsanto is not taking the San Diego Superior Court jury's decision lying down. We will immediately seek to have this award set aside, [because] no past or future damages were suffered by Mycogen, says David Snively, assistant general counsel for Monsanto. At the center of the dispute is enabling biotechnology that allows the creation of a whole new generation of crops. Monsanto has technology that enables insertion of modified Bacillus thuringiensis ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
